Anthony S. TangOttawa, ON, Canada
|
RAFT
The Resynchronization/defibrillation for Ambulatory heart Failure Trial (RAFT)
|
|
|
Keith D. Aaronson
University of Michigan
|
ADVANCE
Evaluation of the HeartWare® HVAD Left Ventricular Assist Device System for the Treatment of Advanced Heart Failure: Results of the ADVANCE Bridge to Transplant Trial.
|
|
Adrian F. Hernandez
Duke Clinical Research Institute
|
ASCEND-HF
Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)
|
|
Faiez Zannad
University of Nancy
|
EMPHASIS-HF
The Effect Of Eplerenone Versus Placebo On Cardiovascular Mortality Or Heart Failure Hospitalization In Subjects With Nyha Class Ii Chronic Systolic Heart Failure. Emphasis-hf
|
|
Kenneth Mahaffey
Duke University
|
ROCKET AF
Stroke Prevention Using the Oral Direct Factor Xa inhibitor Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation (ROCKET AF)
|
|
Kenneth A. Ellenbogen
Medical College of Virginia
|
SMART AV
Primary Results from the SMART AV Trial: A Randomized Trial Comparing Empiric, Echocardiographic Guided and Algorithmic AV Delay Programming in Cardiac Resynchronization Therapy (CRT)
|
|
Peter R. Kowey
Lankenau Hospital
|
Fish Oil for AF
Efficacy And Safety Of Prescription Omega-3-Acid Ethyl Esters (P-OM3) For The Prevention Of Recurrent Symptomatic Atrial Fibrillation (AF)
|
|
Anthony Furlan
University Hospital
|
CLOSURE I
CLOSURE I: A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients with a Stroke or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale
|
|
Matthew J. Price
Scripps Clinic
|
GRAVITAS
Standard Versus High-Dose Clopidogrel According to Platelet Function Testing After PCI: Results of the GRAVITAS Trial
|
|
|
William R. Hiatt
University of Colorado Denver
|
TAMARIS
NV1FGF Gene Therapy on Amputation-Free Survival in Critical Limb Ischemia - Phase 3 Randomized Double-Blind Placebo-Controlled Trial
|
|
Christoph A. Kaiser
University Hospital, Basel
|
BASKET PROVE
Late Cardiac Death And Myocardial Infarction Associated With Late Stent Thrombosis In Large Vessel Stenting After 1st Or 2nd Generation Drug-eluting Compared To Bare-metal Stents: the BASKET PROspective Evaluation Examination (BASKET PROVE)
|
|
Otavio Berwanger
Sao Paulo Cardiac Hospital
|
ACT
Acetylcystein for the Prevention of Contrast-Induced nephropaThy (ACT) Trial: a Pragmatic Multicenter Randomized Trial to Evaluate the Efficacy of Acetylcysteine for the Prevention of Renal Outcomes in Patients Undergoing Coronary and Vascular Angiography
|
|
Peter S. Sever
University of Glasgow
|
ASCOT
The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT): Testing C-Reactive Protein at baseline and on-treatment as an independent predictor of cardiovascular outcomes
|
|
Christopher P. Cannon
TIMI Study Group
|
DEFINE
Primary Results of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib
|
|
Stephen J. Nicholls
Cleveland Clinic
|
The ASSERT Study
Results of the First Major Clinical Trial of An Oral Agent Inducing Apo A1 Synthesis: A New Approach to HDL Raising and CV Risk Modification
|
|
Murray Esler
Baker IDI Heart and Diabetes Institute
|
Symplicity HTN-2
Symplicity HTN-2: International, Multicenter, Prospective, Randomized, Controlled Trial Of Endovascular Selective Renal Sympathetic Denervation For The Treatment Of Hypertension
|
|
